| ASCVD | atherosclerovascular disease |
| LDL | low-density lipoprotein |
| HDL | high-density lipoprotein |
| oxLDL | oxidized low-density lipoprotein |
| VEGF | vascular endothelial growth factor |
| TNF-α | tumor necrosis factor-alpha |
| IL | interleukin |
| IFN-γ | interferon-gamma |
| SASP | senescence-associated secretory phenotype |
| ROS | reactive oxygen species |
| DDR | DNA damage response |
| NO | nitric oxide |
| PGI2 | prostacyclin |
| TS3 | Type III Secretion System |
| Hfq | Host Factor for RNA Binding |
| mTOR | mammalian target of rapamycin |
| HMGCR | 3-hydroxy-3-methylglutaryl-coenzyme a reductase |
| LXR-α | liver X receptor-alpha |
| PPAR-γ | peroxisome proliferator-activated receptor-gamma |
| ABCA1 | ATP-binding cassette transporter A1 |
| ApoB | apolipoprotein B |
| GDP | Guanosine Diphosphate |
| 5-FU | 5-fluorouracil |
| TG | triglyceride |
| ICAM-1 | Intercellular Adhesion Molecule 1 |
| VCAM-1 | Vascular Cell Adhesion Molecule 1 |
| ADT | androgen deprivation therapy |
| SERMs | selective estrogen receptor modulators |
| AIs | aromatase inhibitors |
| TKIs | tyrosine kinase inhibitors |
| PD-1 | Programmed Death-1 |
| CTLA4 | Cytotoxic T-Lymphocyte-Associated Protein 4 |
| CVD | cardiovascular disease |
| CRP | C-reactive protein |
| ARB | angiotensin receptor blocker |
| CVAD | cardiovascular adverse disease |
| TMA | trimethylamine |
| TMAO | trimethylamine-N-oxide |
| SCFAs | short-chain fatty acids |